David Mott

Polyneuron is a growing Basel-based biotechnology company active in the area of autoimmune disease treatments. The company was founded in 2014 as a spinout company from the University of Basel to develop novel treatments to combat immune disorders using its Antibody-Catch™ technology platform. The company currently employs about 10 people and has raised a significant amount in equity funding from top-tier VCs. We are a team of passionate and experienced scientists, entrepreneurs and investors willing to bring new therapies to patients.

Clementia Pharmaceuticals is a biotechnology company based out of 1375 TransCanada Highway, Suite 200, Dorval, Quebec, Canada.

XTuit Pharmaceuticals, Inc., was founded in 2011 by Harvard Professor Rakesh Jain, MIT Professor Bob Langer, and Polaris partner Alan Crane. The company is pursuing novel approaches to improving cancer therapy by targeting the tumor microenvironment.

Nightstar Therapeutics plc (NASDAQ: NITE) is a leading clinical-stage gene therapy company focused on developing and commercializing novel one-time treatments for patients suffering from rare inherited retinal diseases including choroideremia, X-linked retinitis pigmentosa and Best vitelliform macular dystrophy.

Edimer Pharmaceuticals: Working toward improving the health and quality of life of families living with XLHED. Edimer Pharmaceuticals is dedicated to developing EDI200 as a treatment for X-linked Hypohydrotic Ectodermal Dysplasia (XLHED). XLHED is a rare, orphan disease that causes a range of symptoms including lack of sweat glands, poor temperature control, respiratory problems, and hair and tooth malformations. Edimer is led by a team of seasoned biotechnology industry veterans with deep experience in drug development complemented by a strong network of world-class clinical and scientific advisers. The company is based in Cambridge, Massachusetts.

Omthera Pharmaceuticals, Inc. is an emerging specialty pharmaceuticals company focusing its efforts on the clinical development of new therapies for dyslipidemia. Led by a team of experts with exceptional experience in developing new therapies for lipid disorders, Omthera is dedicated to developing innovative therapies for the millions of patients who have elevated triglyceride levels and increased risk of cardiovascular disease.

Shire is now part of Takeda. Follow us at https://www.linkedin.com/company/takeda-pharmaceuticals/

American Rivers protects wild rivers, restores damaged rivers, and conserves clean water for people and nature. Since 1973, American Rivers has protected and restored more than 150,000 miles of rivers through advocacy efforts, on-the-ground projects, and an annual America’s Most Endangered Rivers® campaign. Headquartered in Washington, DC, American Rivers has offices across the country and more than 200,000 members, supporters, and volunteers. American Rivers maintains a positive work environment with a culture of learning, support and balance. For more information please visit www.americanrivers.org.

The Yellowstone Club Community Foundation was established in 2010 and serves as a resource for the Greater Big Sky and Gallatin Valley area. The Foundation is supported by the members, friends, and the ownership/management of the Yellowstone Club who are grateful for the opportunity to help serve the community. In working together, we can help keep our community happy, healthy and prosperous. We are honored to partner with fantastic nonprofits addressing difficult issues including hunger, veteran reintegration, education, and healthcare. We also support local organizations bringing arts and cultural opportunities to all ages in our communities and conserving and protecting our area’s magnificent natural environment.

Big Sky Youth Empowerment (BYEP) provides opportunities for vulnerable teenagers to experience success with the goal of becoming contributing members of the community through group mentoring and outdoor adventures. Youth voluntarily apply to BYEPs six year program with no cost to the family. The program engages teens in both experiential adventures and a social emotional life skills curriculum. Our curriculum covers developmentally appropriate topics such as conflict resolution, trust and teamwork, communication, identity, healthy relationships, suicide awareness, drug education, and sexual reproductive health. Adventures such as skiing and snowboarding, rock climbing, and whitewater rafting provide opportunities for youth to “get outside and grow inside” while practicing the social emotional skills and tools they are learning in workshops.

We’re focused on using our proven vaccine technology to protect health by developing our R&D assets and establishing partnerships. We stand strong against infectious diseases and viral threats—our science grounds us, our technology pushes us forward, our commitment inspires us to achieve our mission of ensuring broad access to our vaccines. It’s more than our job. It’s our passion. Our Novavax Social Community Guidelines: https://www.novavax.com/social-media-community-guidelines